Summary We studied whether fibronectin (FN) enhances the activity of autologous tumour-reactive cytotoxic T lymphocytes (CTLs) generated from cancer patients. The proliferation of CTLs stimulated by immobilised anti-CD3 monoclonal antibody and interleukin 2 (IL-2) was 
The adoptive immunotherapy (AIT) for advanced cancer patients with lymphokine-activated killer (LAK) cells or tumour-infiltrating lymphocytes (TILs) has been considered to be a valuable strategy in cancer therapy. However, the initially encouraging results from Rosenberg, et al. (1987 Rosenberg, et al. ( , 1988 have failed to translate into a reliable approach to treatment when studied by other authors. For the improvement of clinical efficacy, many studies of effector cells and their culture methods have been performed. We have reported that AIT, using TILs activated by interleukin 2 (IL-2) and interleukin 4 (IL-4), is considered to be useful in cancer patients with malignant ascites (Yamaue et al., 1990; Tsunoda et al., 1991 Tsunoda et al., , 1992 . However, TILs cannot be induced in all the patients, and they usually require a long culture period.
We, therefore, studied cytotoxic T lymphocytes (CTLs) induced by autologous mixed lymphocyte tumour culture (AMLTC), and demonstrated that CD4+ CTLs generated by immobilised anti-CD3 monoclonal antibody (MAb) had both helper and killer functions, and they were effective for AIT in cancer patients (Tani et al., 1995) .
Fibronectin (FN) is a one of the macromolecules that promote cell adhesion, cell migration and differentiation. Recently, FN was reported to augment the proliferation of human peripheral blood lymphocytes (PBLs) by combination with immobilised anti-CD3 MAb Matsubayashi et al., 1989; Cardarelli et al., 1991; Davis et al., 1990) . However, there is no report that clarifies whether FN augments the proliferation and the activation of CTLs induced by AMLTC from cancer patients.
The present study was designed to clarify whether FN promotes the proliferation and activation of CTLs, and to present the functional characteristics of CTLs stimulated by FN.
Materials and methods Patients
Peripheral blood mononuclear cells (PBMCs) were obtained from 16 patients with malignant diseases (one thyroid cancer, four gastric cancer, one duodenal cancer, one colonic cancer, three gallbladder cancer, one gallbladder carcinosarcoma, one ovarian cancer, one malignant methothelioma of the peritoneum, one leiomyosarcoma of retroperitoneal region, one angiosarcoma and one adenocarcinoma of unknown origin) (Table I) . AMLTC PBMCs separated from heparinised peripheral blood were obtained from cancer patients by Ficoll-Hypaque (Pharmacia, Uppsala, Sweden) gradient centrifugation (400 g, 30 min, 20°C). The PBMCs, suspended at 2 x 106 ml-1 in RPMI-1640 medium (Nissui, Tokyo, Japan) supplemented with 2 mM Lglutamine, 100 U ml-penicillin, 100 Mg ml-streptomycin, 50 giM 2-mercaptoethanol and 5% heat-inactivated human AB serum (Nipro, Osaka, Japan) (complete medium), were used as responder cells (R).
Fresh excised tumour tissues were processed by enzymatic digestion as described previously (Tani et al., 1995; Yamaue et al., 1991; Yamaue et al., 1992; Iwahashi et al., 1992) . Briefly, tumour tissues were dissected into pieces smaller than 2 mm3 and these were immersed in medium containing collagenase (2 mg ml-', type V-S; Sigma, St Louis, MO, USA), hyaluronidase (10 U ml-', type IV-S; Sigma) and DNAase-I (0.4 mg ml-'; Sigma). After 40 min incubation, cells obtained from solid-tumour specimens and ascites were centrifuged on Ficoll-Hypaque gradients at 400 g for 30 min, and the cells were centrifuged on discontinuous gradients consisting of 100% and 75% Ficoll-Hypaque at 400 g for 30 min. The tumour-cell-rich fraction was then layered on discontinuous gradients containing 25%, 15% and 10% Percoll (Pharmacia) and centrifuged at 25 g for 7 min. Tumour cells depleted of lymphoid cells were collected from the bottom and from the 25% interface, and were then washed and suspended in complete medium. The 51Cr-release assays (CRA) were performed to assess killer cell cytotoxicity, as described Yamaue et al., 1987 Yamaue et al., , 1989 Since we have been culturing CTLs stimulated by 10 pg ml-' immobilised anti-CD3 MAb and 250 IU ml-' IL-2 for adoptive immunotherapy of cancer patients (Tani et al., 1995) , we examined the effect of immobilised FN on CTLs stimulated by 10 ,ug ml-' immobilised anti-CD3 MAb and 250 IU ml-' IL-2 (Table II) . The enhancement of proliferation of CTLs was observed by immobilised FN at concentrations of 2 -50 pg ml -' (P < 0.05). The proliferative effect of immobilised FN (ranged from 2-50 Mg ml-') was observed at a significant level (P<0.05). The proliferative effect of 10 Mg ml-' immobilised FN was significantly higher compared with those of other doses of immobilised FN. Therefore, the dose of 10 Mg ml-' FN was used for all subsequent studies.
Moreover, the cell numbers of CTLs stimulated by immobilised FN was three or four times higher than CTLs stimulated without FN (Figure 2 ). On the other hand, the soluble FN did not alter the proliferation and cell numbers of CTLs stimulated by immobilised anti-CD3 MAb and 250 IU ml-' of IL-2 (data not shown). (Table IV) .
MHC restriction of CTLs generated by immobilised FN As shown in Table V , the autologous tumour killing activity was suppressed by anti-HLA class I MAb, whereas it was not altered by anti-HLA-DR MAb. These findings indicate that HLA class I restricted CTLs were generated by immobilised FN. We examined the phenotypes of these CTLs by a negative selection method employing immunomagnetic Phenotypes of CTL activated by immobilised FN were determined by negative selection method employing immunomagnetic beads separation. In blocking assay, 5 pgmlr1 anti-HLA class I MAb or anti-HLA-DR MAb was used. The autologous tumor-killing activity was determined by 4 h 5'Cr-release assay. CTL were induced froni patients with one colonic cancer (case 7) and one gallbladder cancer (case 8).
Table VI Cytokine production by CTL IL-2 (pg mrl') IFN-y (pg ml-') GM-CSF (pgml1) IL-4 (pg mrl') IL-6 (pg mrl')
Case 8  0  823  11  41  31  464  5  14  236  306  Case9  282  316  10  46  49  2156  11  97  135  158  Case 10  162  698  0  29  61  340  0  27  772  1362  Case 12  50  75  7  30  59  70  0  0  395  480  Case 13  318  380  1  8  714  3112  NT  NT  NT  NT Cytokine production by CTL was measured. CTL were induced from the three patients with gallbladder cancer (cases 8-10), one ovarian cancer (case 12) and one malignant methothelioma of peritoneum (case 13). Cytokine production including IL-2, IFN-y and GM-CSF was augmented by FN stimulation (*P<0.05).
separation. The autologous tumour killing activity of these CTLs was suppressed by the elimination of CD4+ cells. These results indicate that CD4+ CTLs are strongly cytotoxic against autologous tumour cells.
Cytokine activity produced by CTLs The cytokine production by CTLs immediately after AMLTC induced from five patients (three gallbladder cancer, one ovarian cancer and one malignant methothelioma of the peritoneum) was studied. As shown in Table VI the cytokine production of CTLs was augmented by FN stimulation. In particular, the production of IL-2, IFN-y and GM-CSF was significantly augmented by FN stimulation (P< 0.05).
Discussion
Rosenberg et al. (1987, 1988) (Yamaue et al., 1990; Tsunoda et al., 1992) .
However, TILs cannot be induced in all cancer patients. Therefore, we have chosen CTL induction by AMLTC to overcome the problems of using TILs in AIT. Although AIT using CTLs has been shown to be effective in clinical trials, CTLs induced by AMLTC are not sufficiently proliferated by IL-2 alone (Maeda et al., 1989; Aruga et al., 1991) . We have reported that CTLs can be sufficiently proliferated by immobilised anti-CD3 MAb and IL-2 (Tani et al., 1995) . However, finding methods by which CTLs can be proliferated more extensively is an important research area. The extracellular matrix (ECM) is composed of a number of macromolecules that promote cell adhesion, cell migration and differentiation. Recently, ECM, such as FN, laminin and collagen, has been reported to co-stimulate the DNA synthesis of human PBLs Matsuyama et al., 1989) . It We have reported that the surface phenotypes of CTLs activated with immobilised anti-CD3 MAb and IL-2 were predominantly CD3+ and CD4+ (Tani et al., 1995) . In the present study, CTLs activated with immobilised FN showed more predominantly CD4+ T cells, and the autologous tumour killing activity was suppressed by the elimination of CD4+ CTLs.
Two types of mouse CD4+ Th cell clones differ in their lymphokine production pattern (Mosmann et al., 1986) . It has been reported that the restricted cytokine profiles exist in human CD4+ T-cell populations (Maggi et al., 1991) . Thl cells secrete IL-2, IFN-y and lymphotoxin, but they do not secrete IL-4, IL-5 or IL-6. On the other hand, Th 2 cells secrete IL-4, IL-5 and IL-6, but they do not produce IL-2, IFN-y or lymphotoxin. Moreover, it has been reported that Th 0 cells, which secreted a broad spectrum of cytokines, including IL-2, IL-3, IL-4, IFN-y and TNF, were found (Firestein et al., 1989; Mosmann et al., 1991) . Since we studied the cytokine production profiles in bulk culture CTLs, not in CTL clones, we could not find the difference of response between Thl, Th2 and ThO by FN stimulation. However, immobilised FN up-regulated the production of IL-2, IFN-y and GM-CSF in bulk culture. The results suggested that FN might stimulate the activity of TH1 cells, and upregulated cytokine production might induce the strong autologous tumour killing activity.
CTLs stimulated by IL-2 alone appear to be CD8+ cell and MHC class I restricted, since their cytotoxicity has been shown to be inhibited by anti-HLA class I MAb and by elimination of CD8+ cells (Sato et al., 1986; Maeda et al., 1989; Aruga et al., 1991; loannides et al., 1991) . However, we have reported that CD4+ CTLs generated by immobilised anti-CD3 MAb and IL-2 are involved in the cytotoxicity against autologous tumour cells and restricted by HLA-DR (Tani et al., 1995 
